Galena Biopharma to Present at the Lazard Capital Markets 9th Annual
LAKE OSWEGO, Oregon, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc.
(Nasdaq:GALE), a biotechnology company focused on developing innovative,
targeted oncology treatments that address major unmet medical needs to advance
cancer care, today announced that Mark J. Ahn, Ph.D., President and CEO, will
present a corporate overview at the Lazard Capital Markets 9th Annual
Healthcare Conference. The presentation will take place on Tuesday, November
13, 2012 at 2:30 p.m. EST at The Pierre Hotel in New York, NY.
The presentation will be webcast and available on the Company's website at
About Galena Biopharma
Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based
biopharmaceutical company that develops innovative, targeted oncology
treatments that address major unmet medical needs to advance cancer care. For
more information please visit us at www.galenabiopharma.com.
The Galena Biopharma, Inc. logo is available at
CONTACT: Madeline Hatton
Toll free: +1 (855) 855-GALE (4253), ext. 109
IR Sense, LLC
+1 (503) 400-6995
Galena Biopharma, Inc.
Press spacebar to pause and continue. Press esc to stop.